The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Gender differences in antidepressant drug response
Abstract
Epidemiological studies suggest there are considerable differences in the prevalence and presentation of depression in men and women. Women are more than twice as likely to be diagnosed with depression and may also report more atypical and anxiety symptoms than men. Men and women also differ in the metabolism and distribution of antidepressants and the presence of oestrogen in women of childbearing age may interfere with the mechanism of action of a number of antidepressants. These differences have led many researchers to question whether antidepressants are equally effective and tolerated in men and women. While some reports suggest that selective serotonin re-uptake inhibitors (SSRIs) are more effective and result in fewer adverse drug reactions in women than tricyclic antidepressants (TCAs), gender differences in antidepressant response remains a controversial topic. The potential effects of antidepressant exposure in utero and in breast milk further complicate treatment options for antenatal and postnatal depression. While some research suggests the SSRI paroxetine is teratogenic, further carefully designed naturalistic studies are required to fully evaluate these effects. Finally, response to antidepressants and the occurrence of adverse drug reactions is marked by inter-individual variability which may be in part due to genetic differences. Future studies should therefore consider genotypes of the mother, foetus and infant in antidepressant response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“…re-uptake inhibitor reboxetine (Berlanga & Flores-Ramos, 2006) and this finding was further supported by results from the STAR*D study which included over 2876 patients treated with citalopram and suggested that women were more likely to respond to this drug than men (Trivedi et al., 2006).”
ResultCohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
Fava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927
Depressive Symptoms among Pregnant Women Screened in Obstetrics Settings
Marcus, S. M., Flynn, H. A., Blow, F. C., & Barry, K. L. (2003) · Journal of Women's Health · doi:10.1089/154099903765448880 · Cited by 742
Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001926 · Cited by 529
Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0713 · Cited by 521 · cited 1×
“Other reports have suggested that anxious depression is associated with poorer response to all antidepressants (Fava et al., 1997; Fava et al., 2008; Flint & Rifat, 1997) or treatment resistance (Souery et al., 2007).”
BackgroundSex and suicide: Gender differences in suicidal behaviour
Hawton, K. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.6.484 · Cited by 504 · cited 1×
“It has long been recognized that gender differences exist in suicidal behaviour (Hawton, 2000), and while suicidal ideation is considered a symptom of depression, reports of treatment emergent suicide (TESI) and treatment worsening suicide (TWOSI) are common in antidepressant treatment (Donovan et…”
BackgroundUse of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495
Major depressive subtypes and treatment response
Fava, M., Uebelacker, L. A., Alpert, J. E., Nierenberg, A. A., Pava, J. A., & Rosenbaum, J. F. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00440-4 · Cited by 247
Biegon, A., Reches, A., Snyder, L., & McEwen, B. S. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90053-x · Cited by 246
Phenomenology and Course of Generalised Anxiety Disorder
Yonkers, K. A., Warshaw, M. G., Massion, A. O., & Keller, M. B. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.168.3.308 · Cited by 242
Sex, trauma, stress hormones and depression
Young, E., & Korszun, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.94 · Cited by 235 · cited 1×
“Recent compelling evidence suggests that the special relationship between serotonin and oestrogen may also be relevant to the pathogenesis and treatment of mood disorders (Young & Korszun, 2010).”
BackgroundOverweight and Obesity Affect Treatment Response in Major Depression
Kloiber, S., Ising, M., Reppermund, S., Horstmann, S., Dose, T., Majer, M., Zihl, J., Pfister, H., Unschuld, P. G., Holsboer, F., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.001 · Cited by 208
Fink, G., Sumner, B., Rosie, R., Wilson, H., & McQueen, J. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00082-0 · Cited by 198
Treatment of depression with atypical features: a meta-analytic approach
Henkel, V., Mergl, R., Allgaier, A.-K., Kohnen, R., Möller, H.-J., & Hegerl, U. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.07.012 · Cited by 161 · cited 1×
“More recent reports have also suggested that SSRIs are as equally effective as MAOIs in the treatment of atypical depression (Henkel et al., 2006) and TCAs are less effective than SSRIs (Joyce et al., 2002).”
BackgroundClinical implications of the pharmacology of sertraline
WARRINGTON, S. J. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199112002-00004 · Cited by 119
Estrogen Augmentation of Antidepressants in Perimenopausal Depression: A Pilot Study
Morgan, M. L., Cook, I. A., Rapkin, A. J., & Leuchter, A. F. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0617 · Cited by 104
Perroud, N., Uher, R., Marusic, A., Rietschel, M., Mors, O., Henigsberg, N., Hauser, J., Maier, W., Souery, D., Placentino, A., et al. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-60 · Cited by 57 · cited 1×
“Specifically, men treated with nortriptyline were more likely to suffer from increasing suicidal ideation during treatment (Perroud et al., 2009).”
BackgroundSelf-citation
Cited by
Gender differences in depression
Parker, G., & Brotchie, H. (2010) · International Review of Psychiatry · doi:10.3109/09540261.2010.492391 · Cited by 756
Li, S. H., & Graham, B. M. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30358-3 · Cited by 579
Sex differences in anxiety disorders: Interactions between fear, stress, and gonadal hormones
Maeng, L. Y., & Milad, M. R. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.04.002 · Cited by 375
Cuijpers, P., Weitz, E., Twisk, J., Kuehner, C., Cristea, I., David, D., DeRubeis, R. J., Dimidjian, S., Dunlop, B. W., Faramarzi, M., et al. (2014) · Depression and Anxiety · doi:10.1002/da.22328 · Cited by 158
“[40] From a research perspective, the current analysis again raises the question of the extent to which the mechanisms through which CBT and pharmacotherapies work differ for men and women.[41] We also wish to acknowledge, however, that response is not the only important outcome of treatment, and other factors may be…”
BackgroundWang, Y.-C., Tai, P.-A., Poly, T. N., Islam, M. M., Yang, H.-C., Wu, C.-C., & Li, Y.-C. (. (2018) · Behavioural Neurology · doi:10.1155/2018/5315098 · Cited by 115
Metadata
- Authors
- Keers, R., & Aitchison, K. J.
- Venue
- International Review of Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2010-10
- Volume
- 22
- Issue
- 5
- Pages
- 485-500
- ISSN
- 0954-0261 (ISSN-L)
- 1369-1627
- OpenAlex
- W2148523147
- Cited by
- 185
- References
- 18
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.